Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
1(10%)
Results Posted
75%(3 trials)
Terminated
3(30%)

Phase Distribution

Ph phase_3
2
20%
Ph phase_2
1
10%
Ph not_applicable
2
20%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(4)
Terminated(3)
Other(2)

Detailed Status

Completed4
Terminated3
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
57.1%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 32 (33.3%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

recruiting110%
terminated330%
completed440%
unknown220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
10